COVID-19 Advisory for Healthcare Providers

Resources for HealthCare Providers: Multisystem Inflammatory Syndrome (MIS-C) Educational Materials and Request to Report Cases in Pediatric and Adult Patients

Posted Oct. 1, 2021. Past health advisories and alerts are archived for historical purposes and are not maintained or updated.

Please ensure that this information is shared with the appropriate personnel in your facility. Thank you.

The purpose of this health advisory is to encourage surveillance for suspected Multisystem Inflammatory Syndrome cases in children (MIS-C) and adults (MIS-A) in Spokane County, and to share new educational materials from CDC on this topic.

Correlating with the dominance of the delta variant, hospitalization rates among pediatric COVID 19 cases have increased nationally, statewide, and in Spokane County since June of this year. This may result in an increase of MIS-C cases. To date, three confirmed pediatric MIS-C cases have been reported in Spokane County, with an additional case under investigation. A summary of the confirmed MIS-C cases reported in Washington state as of 8/31/2021 is available at:Multisystem Inflammatory Syndrome in Children Associated with COVID-19 in Washington State

Please report any suspected cases of MIS-C in pediatric or adult patients to SRHD by secure email to or fax to 509.324.3623.

The Centers for Disease Control and Prevention (CDC) has developed and tested new materials to support healthcare professionals (HCPs) in diagnosing and treating multisystem inflammatory syndrome in children (MIS-C). MIS-C is a rare, but serious complication associated with COVID-19 in children, adolescents, and young adults where multiple organ systems can become inflamed. MIS-C symptoms are likely to appear within six weeks after a SARS-CoV-2 infection. Common symptoms may include ongoing fever, along with abdominal pain, vomiting, diarrhea, skin rash, conjunctival injection, and dizziness or lightheadedness with low blood pressure. However, not all children have the same symptoms. CDC is studying the condition, and resources are now available on the CDC website. These include:

  • A visual one-pager on How to Recognize MIS-C that can be printed and posted in provider offices or given to parents of children who have had COVID-19
  • A list of What Parents Need to Know about MIS-C for providers to use with parents
  • For inpatient providers, What Parents Need to Know After Diagnosis of MIS-C